| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 17.87M | — |
| Operating expense | — | — |
| Net income | 1.97M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FRX.TO returned +29.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +46.1% |
| 1 year | +29.7% |
| 5 years | +54.9% |
| 10 years | +478.0% |
| All-time high | $85.86 (Aug 2005) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FRX.TO would be worth today ›No. Fennec Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
Fennec Pharmaceuticals Inc. is part of the Healthcare sector.
Fennec Pharmaceuticals Inc. has a market cap of 543.19M CAD, based on the latest quote.
Fennec Pharmaceuticals Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
